0001209191-19-044243.txt : 20190802 0001209191-19-044243.hdr.sgml : 20190802 20190802162053 ACCESSION NUMBER: 0001209191-19-044243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190731 FILED AS OF DATE: 20190802 DATE AS OF CHANGE: 20190802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carey Thomas D. CENTRAL INDEX KEY: 0001574633 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 19996249 MAIL ADDRESS: STREET 1: 8 PAIGE STREET CITY: HINGHAM STATE: MA ZIP: 02043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 441 CHARMANY DRIVE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-31 0 0001124140 EXACT SCIENCES CORP EXAS 0001574633 Carey Thomas D. C/O EXACT SCIENCES CORP. 441 CHARMANY DRIVE MADISON WI 53719 1 0 0 0 Common Stock 2019-07-31 4 S 0 1337 114.99 D 42844 D Common Stock 2019-07-31 4 S 0 1800 115.89 D 41044 D Common Stock 2019-07-31 4 S 0 1200 117.33 D 39844 D Common Stock 2019-07-31 4 S 0 2436 118.21 D 37408 D Common Stock 2019-07-31 4 S 0 2770 119.30 D 34638 D Common Stock 2019-07-31 4 S 0 457 120.19 D 34181 D The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 26, 2018 to cover certain tax liabilities arising out of the vesting of shares of restricted stock. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.51 to $115.34, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.52 to $116.24, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.72 to $117.72, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.81 to $118.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.85 to $119.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.13 to $120.24, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. /s/ Thomas D. Carey by Mark R. Busch, attorney-in-fact 2019-08-02